Stopping Inflammation in Stroke: Role of ST2/IL-33 Signaling
J Neurosci
.
2017 Oct 4;37(40):9614-9616.
doi: 10.1523/JNEUROSCI.1863-17.2017.
Authors
Antoine Drieu
1
,
Sara Martinez de Lizarrondo
1
,
Marina Rubio
2
3
Affiliations
1
Normandie Univ, UNICAEN, INSERM, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Cyceron, 14000 Caen, France, and.
2
Normandie Univ, UNICAEN, INSERM, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Cyceron, 14000 Caen, France, and rubio@cyceron.fr.
3
Délégation Recherche Clinique et Innovation (DRCI), Caen University Hospital CHU Côte de Nacre, 14000 Caen, France.
PMID:
28978698
PMCID:
PMC6596615
DOI:
10.1523/JNEUROSCI.1863-17.2017
No abstract available
Publication types
Comment
MeSH terms
Brain Injuries
Humans
Inflammation
Interleukin-1 Receptor-Like 1 Protein*
Interleukin-33*
Stroke
Substances
Interleukin-1 Receptor-Like 1 Protein
Interleukin-33